Genprex GNPX
NASDAQ GNPX
$2.56 -0.36 (-12.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Genprex (GNPX) Total Non-Current Liabilities (2024 - 2026)

Updated

Genprex (GNPX) recorded Total Non-Current Liabilities of $2.32 million in Q2 2026, down 30.8% from the prior quarter.

Analysis

Genprex (GNPX) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Genprex reported Total Non-Current Liabilities of $2.17 million, down 13.2% from FY2024.

  • Across earlier years, Total Non-Current Liabilities came in at $2.5 million in FY2024.
  • Quarterly Total Non-Current Liabilities has ranged from $2.17 million in Q4 2025 to $3.35 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $3.35 million (Q1 2026), $2.17 million (Q4 2025) and $2.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Genprex 1.48 Mn -40.66 Mn - 2.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.32 Mn
Mar 31, 2026 3.35 Mn
Dec 31, 2025 2.17 Mn
Sep 30, 2025 2.55 Mn
Dec 31, 2024 2.50 Mn
API Access

Genprex Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GNPX&period=max&api_key=YOUR_API_KEY